Background: Sleep disturbance is common among patients with heart failure (HF) who also experience symptom burden and poor functional performance.
is critical to daytime function, but clinicians fail to address it (Andrews et al., 2013) .
Although the restorative functions of sleep are not completely understood, fatigue, depression, and sleepiness are common in HF and are often consequences of sleep disturbance in many populations (Blinderman, Homel, Billings, Portenoy, & Tennstedt, 2008; Johansson et al., 2012; Jurgens et al., 2009; Lee et al., 2010; Redeker, Jeon, et al., 2010; Redeker & Stein, 2006; Song, Moser, Rayens, & Lennie, 2010) . These sleep-related symptoms may occur singly or in clusters during everyday life with HF ( Jurgens et al., 2009; Lee et al., 2010; Song et al., 2010) and may contribute to voluntary or involuntary decrements in functional performance. The purpose of this report was to evaluate the extent to which sleep-related daytime symptoms (fatigue, sleepiness, and depressive symptoms) mediate the relationship between sleep disturbance and functional performance among patients with stable HF.
METHODS

Design
The study comprised a secondary analysis of data from a crosssectional, observational study conducted between the years 2003 and 2006. The overall purpose of the parent study was to evaluate the extent to which sleep and sleep disorders were associated with daytime symptoms and functional performance among patients with stable HF who were recruited from evidence-based HF disease management settings. Previous reports of the overall study included the direct effects of insomnia (Redeker, Jeon, et al., 2010) and sleep disordered breathing (Redeker, Muench, et al., 2010) on symptoms and function. The investigators also reported the relationships between pain and fatigue (Conley, Feder, & Redeker, 2015) , the contributions of comorbid diabetes to symptoms and function (Fritschi & Redeker, 2015) , and the associations of nocturia with sleep disturbance and function (Redeker et al., 2012) . There have not been substantial changes in care of HF patients since the time of the study, which likely affected the sleep, symptom, and functional performance variables.
The protocol was approved by the committees for protection of rights of human participants in research at the University of Medicine and Dentistry of New Jersey, where the original study took place, each of the recruitment sites, and Yale University, where this secondary analysis was conducted. All participants provided written informed consent.
Sample
Participants included adults who were 18 years of age or older and had stable chronic New York Heart Class I-IV HF. They were recruited from five HF disease management programs in the Northeastern United States. Exclusion criteria included pregnancy, alcohol and/or illicit drug use, Parkinson's disease, obstructive valvular, hypertrophic, or surgically correctable heart disease, previously diagnosed sleep disorders, and endstage renal failure. Participants who had unstable medical or psychiatric conditions, active titration of vasoactive medications, hospitalizations, or emergency department visits for HF within the past month were not excluded, but participation was delayed until participants had been stable on medications and not admitted to the hospital or emergency department for HF for at least 1 month (Redeker, Jeon, et al., 2010) .
Variables and Measures
Functional Performance Because of our interest in the multidimensional aspects of functional performance, we measured self-reported (10-item Medical Outcomes Study Short Form-36 Physical Functional Scale; Ware & Sherbourne, 1992; Ware, Snow, Kosinski, & Gandek, 1993) and objective physical function (Six-Minute Walk Test [6MWT]; Guyatt et al., 1985) . The 6MWT (Guyatt et al., 1985) measures the distance walked in 6 minutes in the clinic setting and is correlated with exercise performance (Lipkin, Scriven, Crake, & Poole-Wilson, 1986 ), functional capacity, and self-reported functional status (Guyatt et al., 1985) . It was conducted with standard methods.
The Medical Outcomes Study SF-36 Physical Function Scale is widely used, valid, reliable, and showed a coefficient alpha of .90 in HF patients (Redeker, Jeon, et al., 2010) . Normbased scoring was used. A higher score indicates better function.
Daytime Symptoms
We measured daytime symptoms that are often associated with sleep disturbance and common among patients with HF (Redeker, Jeon, et al., 2010) , including fatigue (Global Fatigue Index from the Multi-dimensional Assessment of Fatigue Scale, developed from the Piper Fatigue Scale; Piper et al., 1989) , excessive daytime sleepiness (Epworth Sleepiness Scale; Johns, 1991 Johns, , 1992 , and depressive symptoms (Centers for the Epidemiological Studies of Depression Scale; Devins & Orme, 1985; Radloff & Teri, 1986) . These measures are widely used, well validated, and internally consistent among HF patients (Redeker, Jeon, et al., 2010) .
Sleep Disturbance
We used three characteristics to capture the multidimensional nature of sleep disturbance among patients with HF: global sleep quality, insomnia symptoms, and sleep-disordered breathing. Insomnia symptoms were evaluated with three questions from the Sleep Habits Questionnaire used in the Sleep Heart Health Study (Baldwin et al., 2001) ; each item was rated on a 5-item scale with response options ranging from 0: never to 5 = almost always to indicate the frequency with which respondents experienced difficulty initiating or maintaining sleep and/or awakening too early in the morning. We computed a total insomnia score (possible score = 0-15) from the sum of these responses-coefficient alpha was .83 (Redeker, Jeon, et al., 2010) . We also used the score in a dichotomous manner in which the presence of insomnia was defined as a response of "often" or "almost always" to one or more of the three insomnia symptoms.
We measured sleep quality with the Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, & Kupfer, 1989 ), a well-validated and widely used measure of global sleep quality. The PSQI measures seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction over the last month. The PSQI has a range of 0-21; a score of 5 or higher indicates poor sleep quality.
We also conducted full, unattended polysomnography (PSG) in participants' homes for one night and calculated the Respiratory Disturbance Index (RDI; sum of apneas, hypopneas, and respiratory event-related arousals/hour of sleep) as the primary measure of sleep disordered breathingaccording to standard criteria (American Academy of Sleep Medicine Task Force, 1999; Redeker, Muench, et al., 2010) . A higher RDI indicates more severe sleep-disordered breathing. We previously reported full details of the acquisition and scoring of the polysomnographic data (Redeker, Muench, et al., 2010) .
Procedures
Clinic personnel obtained informed consent, reviewed medical records, and administered the 6MWT. Clinic personal referred potential participants to the study. A research assistant explained the study, and certified sleep technicians attached the PSG sensors and set up the recording devices in participants' homes in the evening; PSG was recorded for one night, and the technician returned to pick up the equipment in the morning. Participants completed the study questionnaires while at home. The 6MWT was completed in the clinic setting.
Data Analysis
Data were double entered and converted to SAS data format; all analyses were performed with SAS version 9.3. Descriptive analyses were conducted to evaluate the distribution of demographic and clinical data and the outcome variables. Data analyses were performed with standardized scores computed from the sleep disturbance (insomnia symptoms, sleep quality, RDI), daytime symptoms (fatigue, sleepiness, depression symptoms), and self-reported and objective functional performance variables. Bivariate correlations between the sleep disturbance, daytime symptom, and functional performance variables were computed with Pearson's correlation coefficient.
Main Analysis To examine the extent to which the daytime symptoms mediated the relationships between sleep disturbance and functional performance, we performed structural equation modeling (SEM) with PROC CALIS to estimate the direct effects of sleep disturbance (latent variable indicated by PSQI and insomnia scores) and the indirect (mediation) effects via daytime symptoms (sleepiness [Epworth Sleepiness Scale], depression [Center for Epidemiologic Studies-Depression Scale], fatigue [Global Fatigue Index]) on functional performance (latent variable with indicators PF score and 6MWT distance). This model did not include covariates due to lack of a sufficient sample size. The model estimation was performed using the full information maximum likelihood method to handle missing data. The parameter estimation was constrained by fixing the variances of the latent factors to 1. Goodness of fit was examined using the comparative fit index and the root mean square error of approximation.
Follow-up Exploration
As a follow-up to the SEM and to further explore the relationships among the variables, we computed two regression models. In the first model, we examined the extent to which sleep disturbance predicted daytime symptoms; in the second regression model, we evaluated the extent to which sleep disturbance and daytime symptoms predicted functional performance. In each model, we controlled for age, gender, New York Heart Association Functional Classification, and comorbidity, because these potential confounders were associated with the sleep disturbance, daytime symptom, and/or functional performance variables. The direct effects were evaluated with the coefficient reflecting the association of sleep disturbance with functional performance, adjusted for a mediating variable. The indirect (mediation) effect was estimated as the product of the effect of sleep disturbance on a daytime symptom and the effect of a daytime symptom on functional performance after adjusting for a sleep disturbance variable. We used a bootstrapping approach to estimate the direct and indirect effects and 95% confidence intervals. We calculated direct and indirect effects with 2,000 bootstrap samples with replacement from the entire sample using PROC SURVEYSELECT, SAS version 9.3. The expected direct and indirect effects were obtained from the mean of 2,000 estimates, and 95% confidence intervals were obtained from the 2.5th and 97.5th percentiles of the estimates.
RESULTS
We approached 324 patients, and 173 completed the study. Reasons for exclusion were previously reported (Redeker, Muench, et al., 2010) . Descriptive statistics for the demographic, clinical, sleep disturbance, daytime symptom, and functional performance variables are presented in Table 1 . Some of these characteristics were previously reported (Redeker, Jeon, et al., 2010; Redeker, Muench, et al., 2010) but are repeated in this article to facilitate understanding of the additional analyses presented here. Among the 61 participants who were minority group members, 50 were Black (Redeker, Jeon, et al., 2010) . There were no statistically significant differences in the primary study variables between study sites.
The Pearson correlation coefficients for the associations between the sleep disturbance, daytime symptom, and functional performance variables are shown in Table 2 . Insomnia symptoms and sleep quality were highly correlated with one another, and the RDI was negatively associated with insomnia, but not sleep quality. Insomnia symptoms and sleep quality were significantly associated with all of the daytime symptoms, whereas the RDI had a small, positive association with sleepiness. Sleep quality and insomnia symptoms were associated with self-reported physical function, but only sleep quality was associated with objective physical function (6MWT). The respiratory disturbance was not related to selfreported physical function in the bivariate analyses. Fatigue was significantly associated with self-reported and objective physical function, whereas sleepiness and depression were associated only with self-reported physical function. Self-reported and objective physical functions were moderately correlated with one another. Figure 1 shows the results of the SEM in which we modeled the extent to which the latent variable of daytime symptoms (fatigue, sleepiness, and depression) mediated the relationship between the latent variable of sleep disturbance (insomnia severity, global sleep quality, respiratory disturbance) and the latent variable of functional performance. Because of a small error variance, an estimated error variance of physical function was negative. We addressed the problem by constraining its factor loading to 1. The model had an acceptable comparative fit index of 0.96 and a root mean square error of approximation of 0.05 that indicates a moderate model fit (Bentler, 1990; Browne & Cudeck, 1993) . The latent variable of sleep disturbance was well represented by the observed variables of insomnia severity and global sleep quality on sleep disturbance but poorly represented by respiratory disturbance. The latent variables of daytime symptoms and functional performance were well represented by the observed self-reported variables. A higher level of sleep disturbance was significantly associated with more severe daytime symptoms (b* = 0.73, SE = 0.06, p < .0001). The overall indirect (mediation) effect through the daytime symptoms was statistically significant (mediation effect = −0.47, SE = 0.14, p = .01). The direct effect of sleep disturbance (direct effect = 0.12, SE = 0.15, p = .42) on functional performance was not statistically significant after adjusting for daytime symptoms. Thus, the association between sleep disturbance and functional performance was predominantly explained by the daytime symptoms. Table 3 presents the estimated direct effects of each sleep disturbance variable on the functional performance variables and the indirect (mediation) effects of each daytime symptom between the individual sleep disturbance and functional performance variables. The coefficients and confidence intervals were estimated after adjusting for age, gender, New York Heart Association Functional Classification, and comorbidity from 2,000 bootstrap samples. Insomnia had significant indirect effects on self-reported physical function through fatigue and depressive symptoms on self-reported physical function, and sleep quality had significant indirect effects on selfreported physical function through fatigue and depressive symptoms. There were no statistically significant, indirect effects on objective physical function (6MWT) through the daytime symptoms.
The RDI was not associated with self-reported or objective physical function through any of the daytime symptoms. There was a statistically significant, indirect effect of daytime sleepiness between the RDI and self-reported physical function (Table 3 ). The weak associations of the RDI with sleepiness and self-reported physical function (Table 2 ) resulted in failure to detect a mediation effect. In the overall sample, the RDI was not associated with sleepiness (b* = 0.007, SE = 0.028, p = .81) or self-reported physical function (b = −0.001, SE = 0.014, p = .96).
Participants with insomnia (half of the sample; Redeker, Jeon, et al., 2010) reported more severe sleepiness and poorer functional performance, compared to those without insomnia across all RDI levels. Therefore, we examined the associations between the RDI, sleepiness, and self-reported physical function separately in patients with and without insomnia. Figure 2 shows the means and 95% confidence intervals of self-reported physical function and sleepiness across quartiles of the RDI. Among patients without insomnia, the RDI was positively and significantly associated with sleepiness (r = .34) and negatively associated with self-reported physical function (r = −.20), but there were no relationships among these variables in people with insomnia (sleepiness: r = .03; self-reported physical function: r = −.01). We found a stronger, indirect effect of sleepiness (indirect effect = −0.08, 95% CI [−0.16, −0.01]) between the RDI and self-reported physical function in the subset of patients without insomnia using the bootstrap samples.
DISCUSSION
To our knowledge, this study is the first to examine the extent to which symptoms explain the relationships between sleep disturbance and functional performance in people with stable HF and extends previous studies that focused only on the direct effects of insomnia and other attributes of sleep disturbance on individual and clustered symptoms and functional performance (Bröstrom et al., 2004; Lee et al., 2010; Redeker, 2006; Redeker, Jeon, et al., 2010; Song et al., 2010) . Our findings suggest that daytime symptoms, including depression, fatigue, and excessive daytime sleepiness, explained the relationships between self-reported sleep disturbance and functional performance. The mediation effects support the idea that daytime symptoms may be a causal pathway through which sleep disturbance contributes to functional performance. That is, people who have more severe sleep-related daytime symptoms have lower levels of functional performance.
People who have more severe sleeprelated daytime symptoms have lower levels of functional performance.
As shown in the SEM and further indicated in the regression models, symptoms primarily mediated the effects of self-reported sleep disturbance on self-reported, rather than objectively measured, physical function. Several explanations for these discrepancies are plausible and may be related to differences in the physical function/functional performance constructs or the situations under which they were measured. For example, the SF-36 physical function scale elicits self-reports of the frequencies with which activities are habitually performed during everyday life, whereas the 6MWT is a more specific measure of functional capacity (what the person is able to do), conducted "on demand" in the clinical setting at a single point in time. The negative influence of sleep-related symptoms on functional performance may be voluntary (i.e., people choose not to perform activities due to daytime symptoms) or involuntary (i.e., people are unable to perform activities). It is also possible that negative affectivity explains the stronger associations among the self-reported sleep disturbance, symptoms, and physical function variables compared with the associations with objective functional performance (6MWT). That is, people who perceive symptoms may be more likely to perceive poorer function. Sleep disturbance may be associated with or influence biological and motivational factors that contribute to both daytime symptoms and functional performance. Further studies are needed of the biobehavioral causal mechanisms underpinning the indirect effects observed in this study.
Excessive daytime sleepiness, in contrast to fatigue, is considered a specific symptom of sleep loss (Pigeon, Sateia, & Ferguson, 2003) and is a common outcome of sleepdisordered breathing (obstructive sleep apnea and/or Cheyne-Stokes breathing/central sleep apnea), prevalent among the patients in this study (Redeker, Muench, et al., 2010) and among HF patients in general. However, sleepiness had a smaller, indirect effect on the relationship between sleep .03 [−.11, .17] .01 [−.01, .03] Note. N = 173. The direct effects (effect of sleep disturbance on functional performance after controlling for daytime symptoms) and indirect effects (mediation effect through daytime symptoms) were estimated from 2,000 bootstrap samples with replacement. The effects were adjusted for age, gender, New York Heart Association Functional Classification, and comorbidity. DE = direct effect; DV = dependent variable; IE = indirect effect; IV = independent variable; M = mediator. a Physical Function-Medical Outcomes SF-36 score. b Global Fatigue Index score. c Epworth Sleepiness Scale score. d Center for Epidemiologic Studies-Depression Scale score. e Respiratory Disturbance Index score. **p <.05.
disturbance and physical function than fatigue, and the RDIan indicator of sleep disordered breathing-was negatively associated with insomnia and associated with sleepiness and physical function only in people without insomnia. The reasons for these relationships are not known but may be explained by our earlier finding that the overall level of sleepiness was higher, and self-reported functional performance was lower in people with insomnia (Redeker, Jeon, et al., 2010) compared to those without insomnia. Given that patients often do not fully recognize the extent of their sleepiness, additional study of the role of daytime sleepiness with objective measures, such as the psychomotor vigilance test, is needed to further explain these relationships.
Although insomnia and sleep-disordered breathing are frequently comorbid, especially in HF patients, the relative contributions (or interactive contributions) of these conditions to patient outcomes should be considered in future studies-especially given the unexpected, small, negative association between insomnia severity and RDI in this study.
Differences in the magnitudes and directions of the correlations among the individual sleep disturbance variables and with the individual symptom and functional performance variables likely reflect the multidimensional nature of objective and subjective sleep characteristics and the different dimensions of sleep/sleep disturbance elicited by the respective sleep disturbance variables. For example, the RDI is a measure of sleep-disordered breathing (not sleep itself ), whereas insomnia symptoms are self-reported phenomena that are symptoms or indicators of insomnia-a sleep disorder defined by self-report and self-reported sleep quality is a more general indicator. As with other symptoms, self-reports (e.g., insomnia severity and sleep disturbance) are frequently not closely associated with objective indicators (e.g., RDI).
The effects of sleep disturbance on functional performance, after controlling for clinical and demographic covariates, underscore the importance of sleep disturbance among HF patients-a group for whom daytime symptoms and functional performance are usually attributed primarily to the negative impact of HF itself and suggest the potential benefits of sleep-promoting interventions to symptoms and functional performance in these vulnerable patients. For example, cognitive behavioral therapy for insomnia produced large effects on fatigue among HF patients and improved biomarkers of cardiac risk (Carroll et al., 2015; Irwin et al., 2014 Irwin et al., , 2015 among a sample of older adults of whom the majority had cardiovascular disorders. Meditation and guided imagery may also be efficacious in improving sleep and sleep-related symptoms among these patients Kwekkeboom & Bratzke, 2015) . Further studies are needed of the extent to which behavioral interventions for insomnia improve symptoms and how, in turn, these improvements lead to improved functional performance. Recent evidence that insomnia predicts incident HF and death (Laugsand, Strand, Platou, Vatten, & Janszky, 2014) further underscores the importance of understanding these relationships.
Limitations
Although the findings of this study suggest the meditational role of symptoms, the cross-sectional nature of the study precludes full understanding of the causal nature of the observed relationships among the study variables. Future longitudinal studies and randomized controlled trials are needed to confirm the causal nature of these findings. Cross-sectional studies could produce biased estimates of parameters for longitudinal mediation, especially when there is a perfect mediation (e.g., no direct effect of sleep disturbance on functional performance). Therefore, future studies could use methods such as a cross-lagged panel model for longitudinal data to reduce the biased parameters of mediation in future study (MacKinnon, 2008; Maxwell & Cole, 2007) .
A limitation of the regression analysis, in which we tested multiple models, is the possibility of Type I error and small sample size that may have limited the ability to detect statistically significant effects. This may have also explained the discrepancies between the specific symptoms that mediated the effects of insomnia (fatigue and depressive symptoms) versus sleep quality (fatigue and excessive daytime sleepiness) on physical function. However, taken together, the findings of these analyses are consistent with the results of the SEM in which Type I error is not a concern because of the simultaneous entry of the variables into the model. Nevertheless, future studies should be conducted with larger samples that may have more power to detect significant effects.
Conclusions and Recommendations
Taken together, the findings of this study suggest that daytime symptoms explain the relationships between sleep disturbance and functional performance among patients with stable HF. Future studies are needed to improve understanding of the biobehavioral mechanisms for these relationships, confirm the suggested causal effects, and examine the effects of sleep promoting interventions on sleep disturbance, daytime symptoms, and functional performance.
